The global market size of digital therapeutics (Dtx) is expected to reach US$ 2 billion by 2025 from US$ 0.3 billion in 2018.  

The digital therapeutic industry has been embracing significant changes. The technology is potentially replacing traditional treatment by helping patients control their condition, including how much and what prescription to use. 

Various companies offer alternative treatments for medications. They include evidence-based cognitive behaviour therapy (CBT) in their products. CBT is a widely used form of psychotherapy which is aimed at identifying, challenging and changing unstable behaviour and thinking, thus improving the functioning of patients and influencing behaviour changes.

Likewise, increasing emphasis on preventative healthcare and increased investment in venture capital encourage market growth. The advantages of digital therapy, such as enhanced treatment compliance, the potential to cause behavioural changes and comfort of patients worldwide are also driving the market growth.

The market for digital therapeutic is highly fragmented, diversified and increasingly competitive, with large numbers of small players vying for market space, including start-up companies. Another aspect that is driving its growth is the increase in the number of investors in the market.

The lack of awareness, resistance to digital therapeutic among patients, the resistance from conventional providers of health care and knowledge of patient data privacy are the critical element hindering the growth of the market.